SEC Form 4 · accession 0001225208-19-002978
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. Brennan
Officer — EVP and CFO
Period of report
Feb 14, 2019
Accepted (ET)
Feb 19, 2019 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 14, 2019 | S | 22,438 | $39.5718 | D | 279,183 | D | |
| Common StockF3 | Feb 15, 2019 | M | 4,152 | $0.00 | A | 283,335 | D | |
| Common Stock | Feb 15, 2019 | F | 1,846 | $40.01 | D | 281,489 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF3,F4 | — | Feb 15, 2019 | M | 4,152 | D | — | Feb 15, 2023 | Common Stock | 4,152 | 16,612 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.42 to $39.66, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
Remarks
brennanpoa.txt